Elexacaftor/Tezacaftor/Ivacaftor for Cystic Fibrosis: Impact on Hospitalizations and Health Care Resource Utilization in a Universal Health Care Setting.

Pulm Ther · 2025 · PMC12102036 · PMID 39948204

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

This difference is likely due to an increasing trend in the number of GP visits before ETI initiation (Supplementary Fig. 1) that was not captured in the pre-ETI average used in the main analysis.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.